Q2 2023 · 13F-HR
5AM Venture Management, LLCholdings as filed
Filed 2023-08-14 · accession 0001104659-23-091386
$401.4M
Reported value
24
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $118.3M | 29.5% | 5,798,475 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $66.7M | 16.6% | 4,408,379 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $21.7M | 5.40% | 488,442 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $20.5M | 5.12% | 3,630,724 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $19.7M | 4.90% | 6,361,723 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $18.2M | 4.54% | 357,486 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $15.5M | 3.87% | 862,286 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $13.8M | 3.44% | 490,000 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $12.2M | 3.05% | 1,200,647 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $10.5M | 2.62% | 310,270 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $9.5M | 2.36% | 585,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $9.4M | 2.33% | 790,440 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $8.9M | 2.22% | 587,600 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $7.9M | 1.98% | 320,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $7.4M | 1.84% | 665,555 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $7.3M | 1.81% | 357,733 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $7.0M | 1.73% | 192,500 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $6.7M | 1.66% | 280,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $5.1M | 1.27% | 2,364,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $4.3M | 1.07% | 1,305,000 | Common | SOLE |
| 438083107 | FIXXEUR | HOMOLOGY MEDICINES INC | $4.0M | 1.00% | 4,535,919 | Common | SOLE |
| 45258K109 | — | IMPEL PHARMACEUTICALS INC | $3.7M | 0.91% | 2,884,791 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $1.8M | 0.45% | 152,022 | Common | SOLE |
| 171757107 | — | CIDARA THERAPEUTICS INC | $1.3M | 0.32% | 1,134,511 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.